Green Synthesis of Silver Nanoparticles with Zingiber officinale Extract and Study of its Blood Compatibility

BioNanoScience

Volumn 2, Issue 3, 2012, Pages 144-152

  Kumar, K Praveen ^a   Paul, Willi ^a   Sharma, Chandra P ^a  

^a SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

Author keywords

Blood compatibility; Complement activation; Green synthesis; Silver nanoparticles; Zingiber officinale

Indexed keywords

ATOMIC FORCE MICROSCOPY; BIOCHEMISTRY; BLOOD; CONTROLLED DRUG DELIVERY; GENE TRANSFER; GREEN SYNTHESIS; LIGHT SCATTERING; MEDICAL APPLICATIONS; MEDICINE; METAL NANOPARTICLES; PARTICLE SIZE; REDUCING AGENTS; SILVER METALLOGRAPHY; TARGETED DRUG DELIVERY; TRANSMISSION ELECTRON MICROSCOPY;

BIOMEDICAL APPLICATIONS; BLOOD COMPATIBILITY; COMPLEMENT ACTIVATIONS; PHYSIOLOGICAL CONDITION; STABILIZING AGENTS; SYSTEMIC CIRCULATION; UV-VISIBLE SPECTROPHOTOMETER; ZINGIBER OFFICINALE;

SILVER NANOPARTICLES;

COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C3B; GINGER EXTRACT; SILVER NANOPARTICLE;

ABSORPTION; ANEMOMETRY; ARTICLE; ATOMIC FORCE MICROSCOPY; BLOOD COMPATIBILITY; CELL AGGREGATION; COMPLEMENT ACTIVATION; CONTROLLED STUDY; ERYTHROCYTE AGGREGATION; INTESTINE MUCOSA; LIGHT SCATTERING; NONHUMAN; PARTICLE SIZE; PHOTON CORRELATION SPECTROSCOPY; SYSTEMIC CIRCULATION; THROMBOCYTE ACTIVATION; TRANSMISSION ELECTRON MICROSCOPY; ULTRAVIOLET SPECTROPHOTOMETRY; ZETA POTENTIAL;

EID: 84884213562     PISSN: 21911630     EISSN: 21911649     Source Type: Journal    
DOI: 10.1007/s12668-012-0044-7     Document Type: Article

References (47)

1. Sharma, V. K., Yngard, R. A., Lin, Y. (2009). Silver nanoparticles: green synthesis and their antimicrobial activities. Advances in Colloid and Interface Science, 145, 83-96.
2. Thakkar, K. N., Mhatre, S. S., Parikh, R. Y. (2010). Biological synthesis of metallic nanoparticles. Nanomedicine and Nanotechnology Biology and Medicine, 6(2), 257-262.
3. Goodsell, D. S. (2004). Bionanotechnology: lessons from nature. Hoboken: Wiley.
4. Hutter, E., & Fendler, J. H. (2004). Exploitation of localized surface plasmon resonance. Advanced Materials, 16, 1685-1706.
5. Panacek, A., Kvitek, L., Prucek, R., Kolar, M., Vecerova, R., Pizurova, N., Sharma, V. K., Nevecna, T., Zboril, R. (2006). Silver colloid nanoparticles: synthesis, characterization, and their antibacterial activity. The Journal of Physical Chemistry. B, 110(33), 16248-16253.
6. Kholoud, M. M., El-Nour, A., Eftaiha, A., Al-Warthan, A., Reda, A. A. (2010). Synthesis and applications of silver nanoparticles. Arabian Journal of Chemistry, 3(3), 135-140.
7. Caro, C., Castillo, P. M., Klippstein, R., Pozo, D., Zaderenko, A. P. (2010). Silver nanoparticles: Sensing and imaging applications. In D. P. Perez (Ed.), Silver nanoparticles. ISBN: 978-953-307-028-5, InTech, http://www.intechopen.com/books/silver-nanoparticles/ silver-nanoparticles-sensing-and-imaging-applications.
8. Wu, Q., Cao, H., Luan, Q., Zhang, J., Wang, Z., Warner, J. H., Watt, A. A. R. (2008). Biomolecule-assisted synthesis of watersoluble silver nanoparticles and their biomedical applications. Inorganic Chemistry, 47(13), 5882-5888.
9. Morones, J. R., Elechiguerra, J. L., Camacho, A., Holt, K., Kouri, J. B., Ramirez, J. T., Yacaman, M. J. (2005). The bactericidal effect of silver nanoparticles. Nanotechnology, 16(10), 2346-2353.
10. Lok, C. N., Ho, C. M., Chen, R., He, Q. Y., Yu, W. Y., Sun, H., Tam, P. K., Chiu, J. F., Che, C. M. (2007). Silver nanoparticles: partial oxidation and antibacterial activities. Journal of Biological Inorganic Chemistry, 12(4), 527-534.
11. Ip, M., Lui, S. L., Poon, V. K., Lung, I., Burd, A. (2006). Antimicrobial activities of silver dressings: an in vitro comparison. Journal of Medical Microbiology, 55(Pt 1), 59-63.
12. Silver, S. (2003). Bacterial silver resistance: molecular biology and uses and misuses of silver compounds. FEMS Microbiology Reviews, 27(2-3), 341-353.
13. Arvizo, R. R., Bhattacharyya, S., Kudgus, R. A., Giri, K., Bhattacharya, R., Mukherjee, P. (2012). Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future. Chemical Society Reviews, 41, 2943-2970.
14. Prasad, T. N. V. K. V., Kambala, V. S. R., Naidu, R. (2011). A critical review on biogenic silver nanoparticles and their antimicrobial activity. Current Nanoscience, 7, 531-544.
15. Vijayaraghavan, K., & Nalini, S. P. K. (2010). Biotemplates in the green synthesis of silver nanoparticles. Biotechnology Journal, 5, 1098-1110.
16. Thakkar, K. N., Mhatre, S. S., Parikh, R. Y. (2010). Biological synthesis of metallic nanoparticles. Nanomedicine, 6, 257-262.
17. Florence, A. T. (2005). Nanoparticle uptake by the oral route: fulfilling its potential? Drug Discovery Today: Technologies, 2, 75-81.
18. Tang, J., Xiong, L., Wang, S., Wang, J., Liu, L., Li, J., Yuan, F., Xi, T. (2009). Distribution, translocation and accumulation of silver nanoparticles in rats. Journal of Nanoscience and Nanotechnology, 9(8), 4924-4932.
19. Nurtjahja-Tjendraputra, E., Ammit, A. J., Roufogalis, B. D., Tran, V. H., Duke, C. C. (2003). Effective anti-platelet and COX-1 enzyme inhibitors from pungent constituents of ginger. Thrombosis Research, 111(4-5), 259-265.
20. Black, C. D., Herring, M. P., Hurley, D. J., O'Connor, P. J. (2010). Ginger (Zingiber officinale) reduces muscle pain caused by eccentric exercise. The Journal of Pain, 11(9), 894-903.
21. Sileikaite, A., Prosycevas, I., Puiso, J., Juraitis, A., Guobiene, A. (2006). Analysis of silver nanoparticles produced by chemical reduction of silver salt solution. Materials Science (Medziagotyra), 12(4), 287-291.
22. Lee, P. C., & Melsel, D. (1982). Asorption and surface-enhanced Raman of dyes on silver and gold sols. Journal of Physical Chemistry, 66, 3391-3395.
23. ISO Standard (2008). Particle size analysis-dynamic light scattering (DLS), International Organization for Standards, ISO 22412:2008E 2008.
24. Standard Recommended Practice for the Assessment of the Hemolytic Properties of Materials. (1978). Artificial Organs, 2(3), 318-320.
25. Comell, D. W., & McLachlan, R. (1972). Natural pungent compounds: IV. Examination of the gingerols, shogaols, paradols and related compounds by thin-layer and gas chromatography. Journal of Chromatography, 67(1), 29-35.
26. Yang, W. S., Dong, X. Y., Ji, X. H., Wu, H. L., Zhao, L. L., Li, J. (2009). Shape control of silver nanoparticles by stepwise citrate reduction. Journal of Physical Chemistry C, 113(16), 6573-6576.
27. Goia, D. V. (2004). Preparation and formation mechanisms of uniform metallic particles in homogeneous solutions. Journal of Materials Chemistry, 14, 451-458.
28. Tejamaya, M., Römer, I., Merrifield, R. C., Lead, J. R. (2012). Stability of citrate, PVP, and PEG coated silver nanoparticles in ecotoxicology media. Environmental Science and Technology. doi:10.1021/es2038596.
29. Tolaymat, T. M. (2010). An evidence-based environmental perspective of manufactured silver nanoparticle in syntheses and applications: a systematic review and critical appraisal of peerreviewed scientific papers. The Science of the Total Environment, 408, 999-1006.
30. Römer, I., White, T. A., Baaloushan, M., Chipman, K., Viant, M. R., Lead, J. R. (2011). Aggregation and dispersion of silver nanoparticles in exposure media for aquatic toxicity tests. Journal of Chromatography A, 1218, 4226-4233.
31. Xia, Y., & Halas, N. J. (2005). Shape-controlled synthesis and surface plasmonic properties of metallic nanostructures. MRS Bulletin, 30, 338-343.
32. Kerker, M. (1969). Light and other electromagnetic radiation. New York: Academic.
33. Bohren, C. D., & Huffman, D. R. (1983). Absorption and scattering of light by small particles. New York: Wiley.
34. Creighton, J. A., & Eadon, D. G. (1991). Ultraviolet visible absorption-spectra of the colloidal metallic elements. Journal of the Chemical Society, Faraday Transactions, 87(24), 3881-3891.
35. MacCuspie, R. I. (2011). Colloidal stability of silver nanoparticles in biologically relevant conditions. Journal of Nanoparticle Research, 13(7), 2893-2908.
36. Jani, P., Halbert, G. W., Langridge, J., Florence, A. T. (1989). The uptake and translocation of latex nanospheres and microspheres after oral-administration to rats. The Journal of Pharmacy and Pharmacology, 41(12), 809-812.
37. Shakweh, M., Ponchel, G., Fattal, E. (2004). Particle uptake by Peyer's patches: a pathway for drug and vaccine delivery. Expert Opinion on Drug Delivery, 1(1), 141-163.
38. Nemmar, A., Hoylaerts, M. F., Hoet, P. H., Nemery, B. (2004). Possible mechanisms of the cardiovascular effects of inhaled particles: systemic translocation and prothrombotic effects. Toxicology Letters, 149(1-3), 243-253.
39. Mollnes, T. E., Riesenfeld, J., Garred, P., Nordstrom, E., Hogasen, K., Fosse, E., Gotze, O., Harboe, M. (1995). A new model for evaluation of biocompatibility: combined determination of neoepitopes in blood and on artificial surfaces demonstrates reduced complement activation by immobilization of heparin. Artificial Organs, 19(9), 909-917.
40. Kaplan, K. L., & Owen, J. (1981). Plasma levels of betathromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood, 57(2), 199-202.
41. Chandy, T., & Sharma, C. P. (1996). Effect of liposome-albumin coatings on ferric ion retention and release from chitosan beads. Biomaterials, 17, 61-66.
42. Sharma, C. P. (2001). Blood-compatible materials: a perspective. Journal of Biomaterials Applications, 15(4), 359-381.
43. Xi, T. F., Tang, J. L., Xiong, L., Zhou, G. F., Wang, S., Wang, J. Y., Liu, L., Li, J. G., Yuan, F. Q., Lu, S. F., Wan, Z. Y., Chou, L. S. (2010). Silver nanoparticles crossing through and distribution in the blood-brain barrier in vitro. Journal of Nanoscience and Nanotechnology, 10(10), 6313-6317.
44. Tanabe, M., Chen, Y. D., Saito, K., Kano, Y. (1993). Cholesterolbiosynthesis inhibitory component from zingiber-officinale roscoe. Chemical and Pharmaceutical Bulletin, 41(4), 710-713.
45. Afzal, M., Al-Hadidi, D., Menon, M., Pesek, J., Dhami, M. S. (2001). Ginger: an ethnomedical, chemical and pharmacological review. Drug Metabolism and Drug Interactions, 18(3-4), 159-190.
46. Akhani, S. P., Vishwakarma, S. L., Goyal, R. K. (2004). Antidiabetic activity of Zingiber officinale in streptozotocin-induced type I diabetic rats. The Journal of Pharmacy and Pharmacology, 56(1), 101-105.
47. Mulvaney, P. (1996). Surface plasmon spectroscopy of nanosized metal particles. Langmuir, 12(3), 788-800.